SCHEMBL1106674

SCHEMBL1106674

Nc1ncnc2c1nc(Br)n2[C@@H]1OC(CO)C(O)[C@@H]1O

nearest known ligand 0.79

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NADK O95544 2/20 0.79
HSPA8 P11142 3/20 0.78
HSPA5 P11021 2/20 0.78
RXFP1 Q9HBX9 1/20 0.71
GAPDH P04406 3/20 0.68
HSD17B10 Q99714 1/20 0.68
SMN1; SMN2 Q16637 2/20 0.67
LMNA P02545 1/20 0.67
TP53 P04637 1/20 0.67
HBB P68871 1/20 0.67
ADORA3 P0DMS8 3/20 0.63
SLC28A2 O43868 2/20 0.62
DPP4 P27487 1/20 0.62
MEN1 O00255 1/20 0.62
SLC28A1 O00337 1/20 0.62
MAP3K7 O43318 1/20 0.62
MAPK1 P28482 1/20 0.62
ADORA2A P29274 1/20 0.62
ADORA2B P29275 1/20 0.62
ADORA1 P30542 1/20 0.62

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12030991 1.00 NADK (0.79) NADKHSPA8HSPA5RXFP1GAPDH
SCHEMBL20419274 1.00 NADK (0.79) NADKHSPA8HSPA5RXFP1GAPDH
SCHEMBL6671819 1.00 NADK (0.79) NADKHSPA8HSPA5RXFP1GAPDH
SCHEMBL14435669 1.00 NADK (0.79) NADKHSPA8HSPA5RXFP1GAPDH
SCHEMBL13587343 1.00 NADK (0.79) NADKHSPA8HSPA5RXFP1GAPDH
SCHEMBL440925 1.00 NADK (0.79) NADKHSPA8HSPA5RXFP1GAPDH
SCHEMBL440926 1.00 NADK (0.79) NADKHSPA8HSPA5RXFP1GAPDH
SCHEMBL29707221 0.99 NADK (0.78) NADKHSPA8HSPA5RXFP1GAPDH
SCHEMBL28823544 0.99 NADK (0.78) NADKHSPA8HSPA5RXFP1GAPDH
Phosphoric Acid SCHEMBL8628967 0.94 NADK (0.72) NADKHSPA8HSPA5RXFP1GAPDH

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8153609-B2 Purine nucleotide derivatives LAURAS AS (NO) 2012-04-10 US disclosed
US-20080293665-A1 Purine Nucleotide Derivatives LAURAS AS (NO) 2008-11-27 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080293665-A1 Purine Nucleotide Derivatives CGAS, PDE8A, PDE7A NADK 301/4885HSPA8 2075/4885HSPA5 3164/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.